877 related articles for article (PubMed ID: 11774115)
21. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
Heller J; Kramer HJ; Horácek V
Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
[TBL] [Abstract][Full Text] [Related]
23. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
Matsuda H; Hayashi K; Saruta T
J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
[TBL] [Abstract][Full Text] [Related]
24. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL; Ekhlas A; Nguyen JM; Moranne O
Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
[TBL] [Abstract][Full Text] [Related]
25. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
Agarwal R
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865
[TBL] [Abstract][Full Text] [Related]
26. Captopril plus losartan in early post-infarction. Neurohormonal effects: a pilot study.
Di Pasquale P; Cannizzaro S; Longo AM; Maringhini G; Iachininoto R; Paterna S
G Ital Cardiol; 1997 Dec; 27(12):1256-63. PubMed ID: 9470059
[TBL] [Abstract][Full Text] [Related]
27. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
Miloradović Z; Jovović D; Mihailović-Stanojević N; Milanović JG; Milanović S
Can J Physiol Pharmacol; 2008 Apr; 86(4):210-4. PubMed ID: 18418431
[TBL] [Abstract][Full Text] [Related]
29. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
30. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists.
Campbell DJ
Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S125-31. PubMed ID: 21143285
[TBL] [Abstract][Full Text] [Related]
31. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R
Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
[TBL] [Abstract][Full Text] [Related]
32. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.
Vallon V; Wead LM; Blantz RC
J Am Soc Nephrol; 1995 Apr; 5(10):1761-7. PubMed ID: 7787143
[TBL] [Abstract][Full Text] [Related]
33. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Giubilato A; Paterna S
Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919
[TBL] [Abstract][Full Text] [Related]
34. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
Gainer JV; Morrow JD; Loveland A; King DJ; Brown NJ
N Engl J Med; 1998 Oct; 339(18):1285-92. PubMed ID: 9791144
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
[TBL] [Abstract][Full Text] [Related]
36. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
[TBL] [Abstract][Full Text] [Related]
37. Involvement of central angiotensin II type 1 receptors in LPS-induced systemic vasopressin release and blood pressure regulation in rats.
Shimizu F; Kasai T; Takamata A
J Appl Physiol (1985); 2009 Jun; 106(6):1943-8. PubMed ID: 19359612
[TBL] [Abstract][Full Text] [Related]
38. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
39. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
[TBL] [Abstract][Full Text] [Related]
40. Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro.
Neto-Neves EM; Montenegro MF; Dias-Junior CA; Spiller F; Kanashiro A; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):825-9. PubMed ID: 20406213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
